PRISM BIOLAB

PRISM BioLab is a biotechnology company with PepMetics Technology, a proprietary drug discovery platform. PepMetics Molecules are designed to mimic α-helix or β-turn peptides using unique, stable scaffolds... PRISM BioLab was founded in 2006 by a group of scientists dedicated to creating new drugs based on their technology of peptide mimetic small molecules. More than ten years of research and development has resulted in the clinical pipelines and numerous discoveries of potential seed compounds... PRISM BioLab is committed to maximizing the potential of its PepMetics Technology, transforming the "undruggable" to "druggable" with the aim of finding cures for the incurable.

Primary location: Fujisawa Japan